Patent · US Active

Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches

US11660265B2 · kind B2 · utility

0Cited by

39References

21Claims

0Family size

Assignee

Emergex USA Corporation · US

Inventors

Mahmoud Ameri · Fremont, US
Donald Kellerman · Santa Cruz, US
Peter Daddona · Menlo Park, US
Yi Ao · Palo Alto, US
Peter C. Schmidt · Leverkusen, DE

Key dates

Filing date	Jun 27, 2019
Grant date	May 30, 2023
Priority date	—
Expiry date	Nov 21, 2040

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB05D1/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods for treating migraine by administering zolmitriptan using an adhesive dermally-applied microarray (ADAM) resulting in rapid and durable pain relief, pain freedom and reduction in most bothersome migraine-associated symptoms (MBS), or a combination thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.